FDA Inspection 1084682 — Denton Pharma, Inc.
The FDA completed an inspection of Denton Pharma, Inc. on March 18, 2019 in North Blenheim, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 18, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- North Blenheim, NY (United States)